GORE EXCLUDER AAA Endoprosthesis PXC161200Recalls & reported problems
W. L. Gore & Associates, Inc. · Contralateral Leg · Class 3 · Implant
All models of GORE EXCLUDER AAA Endoprosthesis (81)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00733132609987), received between Sep 5, 2018 and Mar 10, 2026 — classified as 6 injuries.
The most frequently reported specific device problem is “Migration” (1 report).
2 other recalls cover devices cleared under the same FDA submission (P020004); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Migration1
- Patient-Device Incompatibility1
Patient problems
- Aneurysm3
- Insufficient Information2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryMar 10, 2026Adverse Event Without Identified Device or Use Problem
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2012, THIS PATIENT UNDERWENT AN ENDOVASCULAR TREATMENT FOR ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER® AAA ENDOPROSTHESIS. ON (B)(6) 2025, A REINTERVENTION WAS PERFORMED FOR AN UNKNOWN REASON. AN ADDITIONAL CONTRALATERAL LEG WAS IMPLANTED DISTAL TO THE PREVIOUS DEVICE.
Patient problems: Insufficient Information
MAUDE report 24555526 ↗InjuryMar 10, 2026Adverse Event Without Identified Device or Use Problem
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2009, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER®AAA ENDOPROSTHESIS DEVICES. ON AN UNKNOWN DATE AT POSTOPERATIVE FOLLOW-UP, A TYPE I ENDOLEAK WAS IDENTIFIED AT THE DISTAL LEFT SIDE. ON (B)(6) 2026, A REINTERVENTION WAS PERFORMED. TO ADDRESS THE DISTAL TYPE I ENDOLEAK ON THE LEFT SIDE, THE LEFT INTERNAL ILIAC ARTERY WAS EMBOLIZED, AND AN ADDITIONAL STENT GRAFT WAS EXTENDED TO THE LEFT EXTERNAL ILIAC ARTERY. ON THE RIGHT SIDE, AS A PREVENTIVE MEASURE, AN ADDITIONAL STENT GRAFTS (IBE) WERE IMPLANTED AT THE DISTAL RIGHT SIDE. THE PROCEDURE WAS COMPLETED WITH NO EVIDENCE OF ENDOLEAK.
Patient problems: Insufficient Information
MAUDE report 24555376 ↗InjurySep 21, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2012, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT USING GORE® EXCLUDER® AAA ENDOPROSTHESIS FOR ABDOMINAL AORTIC ANEURYSM. NON-GORE BARE METAL STENTS (LUMINEXX) WERE IMPLANTED TO RELINE BILATERAL LEGS. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2021, IT WAS REPORTED THAT BILATERAL COMMON ILIAC BECAME ANEURYSMAL IN THE TREATED AREA. ENDOLEAKS WERE NOTED BILATERALLY. THE BILATERAL INTERNAL ILIAC ARTERIES WERE EMBOLIZED, AND ADDITIONAL STENT GRAFTS WERE DEPLOYED TO EXTEND THE DEVICE TO BILATERAL EXTERNAL ILIAC ARTERY. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 12507557 ↗InjuryJul 21, 2021Migration; Migration
ON (B)(6) 2009, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM USING A GORE® EXCLUDER® AAA ENDOPROSTHESIS. ON AN UNKNOWN DATE, FOLLOW-UP EXAMINATION REPORTEDLY REVEALED A SUSPECTED TYPE IB ENDOLEAK SECONDARY TO PROXIMAL MIGRATION OF THE RIGHT LIMB. THE CAUSE OF THE MIGRATION AND SUSPECTED ENDOLEAK WAS NOT REPORTED. IT WAS UNKNOWN WHETHER ANEURYSM ENLARGEMENT WAS PRESENT. ON (B)(6) 2021, THE PATIENT UNDERWENT A REINTERVENTION PROCEDURE WHEREBY AN ADDITIONAL STENT GRAFT WAS DEPLOYED TO EXTEND THE RIGHT LIMB DISTALLY. NO ENDOLEAK WAS OBSERVED ON FINAL PROCEDURAL ANGIOGRAPH. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 12203220 ↗InjuryFeb 4, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2009, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A LEFT COMMON ILIAC ARTERY ANEURYSM USING TWO GORE(R) EXCLUDER(R) CONTRALATERAL LEG COMPONENTS. ON (B)(6) 2021, THE PATIENT PRESENTED WITH ANEURYSMAL DILATATION OF THE LEFT ILIAC ARTERY. ON THE SAME DAY, THE PATIENT UNDERWENT A RE-INTERVENTION PROCEDURE WHEREBY COIL EMBOLIZATION OF THE LEFT INTERNAL ILIAC ARTERY WAS PERFORMED, AND AN ADDITIONAL GORE(R) EXCLUDER(R) DEVICE WAS IMPLANTED TO EXTEND THE STENT GRAFT SYSTEM DISTALLY. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 11280143 ↗InjurySep 5, 2018Patient-Device Incompatibility; Patient-Device Incompatibility
ON (B)(6) 2006, THE PATIENT UNDERWENT TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH TWO GORE® EXCLUDER® AAA ENDOPROSTHESES. ON (B)(6) 2018, FOLLOW-UP CT IMAGING IDENTIFIED A DISTAL TYPE I ENDOLEAK WITH NO EVIDENCE OF ANEURYSM ENLARGEMENT. IT WAS REPORTED THE CAUSE OF THE ENDOLEAK IS UNKNOWN. ON (B)(6) 2018, AN INTERVENTION WAS PERFORMED TO REPAIR THE DISTAL TYPE I ENDOLEAK FOR DISTAL EXTENSION ON THE PXC1612000. FINAL ANGIOGRAPHY SHOWED RESOLUTION OF THE ENDOLEAK, AND THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 7846188 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P020004. One submission often covers many models, so check the product and lot details in each record.
- Z-0995-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER AAA Endoprosthesis
- Z-0996-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER Iliac Branch Endoprosthesis (IBE)
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page